Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF84 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | NPIPA8 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | FKBP6 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | CFD | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | DEF8 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
mRNA | BRD3 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | ZNF345 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | ZNF491 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
mRNA | RP11-795F19.5 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |